THROMBOTIC MICROANGIOPATHIES
Clinical trials for THROMBOTIC MICROANGIOPATHIES explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHIES trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood disorder: experimental drug TGD001 enters human trials
Disease control Not yet recruitingThis early-phase trial tests a new drug called TGD001 in about 70 adults with acute episodes of immune-mediated thrombotic thrombocytopenic purpura (iTTP) or related blood clotting conditions. The main goal is to check the drug's safety and how the body processes it, while also l…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Phase: PHASE1, PHASE2 • Sponsor: TargED Biopharmaceuticals B.V. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could interferon be a hidden trigger of blood clot damage after transplant?
Knowledge-focused Not yet recruitingThis study investigates how interferon and complement proteins contribute to thrombotic microangiopathy (TMA), a serious condition involving small blood clots and organ damage that can occur after stem cell transplants. Researchers will measure interferon levels, complement activ…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Phase: NA • Sponsor: Sofie Dhaese • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC